PNO1 and glioma: Therefore, cDNA microarrayanalysis, high-throughput sequencing technologies, on-line databases analysis,biochemistry, and molecular biology were applied to evaluate PNO1 as a prognosticbiomarker and its underlying molecular mechanisms of glioma development.